Speakers for 2023 Climate Tech Summit announced. Save your seat today!

For more than 25 years, Paul has used cell engineering and microbiology to find solutions to societal needs like pain treatment, cancer, vaccines, and renewable energy.

Paul is the co-inventor of N-001, a novel, long lasting, non-addictive pain therapeutic.

Paul earned his Ph.D from the University of California, Davis, in 1984, and a B.S. from the University of California at Berkeley. He completed his postdoctoral fellowships at UC Berkeley and Stanford University Medical School.